Clinical trials for Rickets

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Rickets. For all clinical trials, go to clinical trials search

This list shows clinical trials for Rickets

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Rickets
Title Recruitment status Location
Effect of vitaminD3 or 25(OH)D3 Fortified Dairy on Vitmain D Status and CVD Risk Markers Recruiting United Kingdom
A randomized, placebo-controlled trial of BPS804 on safety and tolerability in patients with late-stage chronic kidney disease Not Recruiting United Kingdom
A study of sotatercept given by injection for evaluating the safety, pharmacokinetics (effect of body on drug), and effect on anemia and bone disorder in people with end stage kidney disease on hemodialysis that are switched from erythropoiesis stimulating agents (medication to treat anemia) to sotatercept. Not Recruiting United Kingdom
A study of sotatercept given by injection for evaluating the safety, pharmacokinetics (effect of body on drug), and effect on anemia and bone disorder in people with end stage kidney disease on hemodialysis that are switched from erythropoiesis stimulating agents (medication to treat anemia) to sotatercept. Not Recruiting United Kingdom
A study of sotatercept given by injection for evaluating the safety, pharmacokinetics (effect of body on drug), and effect on anemia and bone disorder in people with end stage kidney disease on hemodialysis that are switched from erythropoiesis stimulating agents (medication to treat anemia) to sotatercept. Authorised United Kingdom
A pilot randomised controlled trial to determine if vitamin D treatment will result in a greater bone mass acquisition in pubertal girls - Influence of vitamin D on bone health in pubertal girls Authorised United Kingdom
A study of sotatercept given by injection for evaluating the safety, pharmacokinetics (effect of body on drug), and effect on anemia and bone disorder in people with end stage kidney disease on hemodialysis that are switched from erythropoiesis stimulating agents (medication to treat anemia) to sotatercept. Authorised United Kingdom
A study of sotatercept given by injection for evaluating the safety, pharmacokinetics (effect of body on drug), and effect on anemia and bone disorder in people with end stage kidney disease on hemodialysis that are switched from erythropoiesis stimulating agents (medication to treat anemia) to sotatercept. Authorised United Kingdom
A Randomized, Open-Label, Phase 3 Study to Assess the Efficacy and Safety of KRN23 Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients with X-linked Hypophosphatemia (XLH) Authorised United Kingdom
A clinical study (Phase II) in hereditary Rickets (XLH) pediatric patients to assess the safety and working of the molecule a an antibody. Authorised United Kingdom

Page last reviewed:

Next review due: